News | July 10, 2013

Reliable Method Found to Detect Congenital Heart Disease for Babies in the Womb

Researchers analyzed 245 high-risk pregnant patients


July 10, 2013 — Researchers have announced the results of a five-year study that shows early fetal echocardiography provides reliable prenatal diagnosis of major congenital heart disease (CHD). First trimester screening looks very promising for detection of heart problems and increases the need for scheduling early and detailed cardiac evaluations.

“We were excited to find that the accuracy of prenatal cardiac screening was over 95.5 percent in our study,” said Elena Sinkovskaya, RDMS, RDCS, Ph.D., primary investigator and an assistant professor of obstetrics and gynecology at Eastern Virginia Medical School.

She and her colleagues analyzed 245 high-risk pregnant patients with prenatal and postnatal ultrasounds. The quality of images provided by the echocardiograms was sufficient to allow for a detailed evaluation of the fetal heart in the large majority of the fetuses scanned.

The study, “Fetal Cardiac Imaging in Early Pregnancy: Analysis of 254 Echocardiograms Performed Between 11+0 and 16+6 Weeks Gestation,” was presented as a poster at the 2013 American Society of Echocardiography (ASE) Annual Scientific Sessions.

For more information: www.asecho.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now